STIM News & Analysis
3 articles
Market Mood
Neuronetics Coverage Started with Buy Rating by B. Riley
B. Riley has begun coverage of Neuronetics, giving the stock a buy rating. This move signals positive expectations for Neuronetics' market performance. The article does not provide specific numbers on the stock's current price or projected targets. For investors, a buy rating typically indicates analyst confidence and could suggest potential appreciation in stock value for Neuronetics (STIM).
Read More: Neuronetics Coverage Started with Buy Rating by B. Riley
Neuronetics (STIM) Reports Q2 2026 Earnings Call Highlights
Neuronetics (STIM) held its second quarter 2026 earnings call on August 11, 2026. The call featured Dan Reuvers, President and CEO, and newly appointed CFO, Nir Naor. They discussed financial and operational results while cautioning that forward-looking statements might differ due to business uncertainties. The company emphasized the importance of non-GAAP financial measures, such as EBITDA, and provided reconciliation with U.S. GAAP results. This earnings call is a crucial update for investors seeking insight into Neuronetics' financial health and future outlook.
Read More: Neuronetics (STIM) Reports Q2 2026 Earnings Call Highlights
Neuronetics (STIM) Share Purchase Worth $481,802 Made by Chernett
Chernett has purchased shares of Neuronetics (STIM) valued at $481,802. This investment reflects confidence in the company's future prospects. The transaction may indicate potential market interest in STIM and could influence trading volumes. Understanding such moves can provide insights into market dynamics surrounding the company.
Read More: Neuronetics (STIM) Share Purchase Worth $481,802 Made by Chernett